ResearcherMonash Medical CentreNo recent work listed
Eva Segelov
Matched on ORCID iD 0000-0002-4410-6144; OpenAlex author ID A5048595984. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 24
2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper
Papers 3
- Update on optimal management for pancreatic cancer: expert perspectives from members of the Australasian Gastrointestinal Trials Group (AGITG) with invited int… First author DOI 10.1080/14737140.2022.2002689↗
- The EUS molecular evaluation of pancreatic cancer: A prospective multicenter cohort trial. Co-author DOI 10.4103/eus-d-20-00230↗
- Current challenges in optimizing systemic therapy for patients with pancreatic cancer: expert perspectives from the Australasian Gastrointestinal Trials Group … Co-author DOI 10.1080/14737140.2017.1369882↗
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- David Goldstein · 2 shared papers, 2017–2022 · strength 0.19
- Paper Update on optimal management for pancreatic cancer: expert perspectives from members of the Australasian Gastrointestin… DOI 10.1080/14737140.2022.2002689↗
- Paper Current challenges in optimizing systemic therapy for patients with pancreatic cancer: expert perspectives from the Aus… DOI 10.1080/14737140.2017.1369882↗
- Florian Lordick · 2 shared papers, 2017–2022 · strength 0.19
- Paper Update on optimal management for pancreatic cancer: expert perspectives from members of the Australasian Gastrointestin… DOI 10.1080/14737140.2022.2002689↗
- Paper Current challenges in optimizing systemic therapy for patients with pancreatic cancer: expert perspectives from the Aus… DOI 10.1080/14737140.2017.1369882↗
- Timothy Jay Price · 2 shared papers, 2017–2022 · strength 0.19
- Paper Update on optimal management for pancreatic cancer: expert perspectives from members of the Australasian Gastrointestin… DOI 10.1080/14737140.2022.2002689↗
- Paper Current challenges in optimizing systemic therapy for patients with pancreatic cancer: expert perspectives from the Aus… DOI 10.1080/14737140.2017.1369882↗
- Lorraine A. Chantrill · 2 shared papers, 2017–2022 · strength 0.19
- Paper Update on optimal management for pancreatic cancer: expert perspectives from members of the Australasian Gastrointestin… DOI 10.1080/14737140.2022.2002689↗
- Paper Current challenges in optimizing systemic therapy for patients with pancreatic cancer: expert perspectives from the Aus… DOI 10.1080/14737140.2017.1369882↗
- Ian Chau · 2 shared papers, 2017–2022 · strength 0.19
- Paper Update on optimal management for pancreatic cancer: expert perspectives from members of the Australasian Gastrointestin… DOI 10.1080/14737140.2022.2002689↗
- Paper Current challenges in optimizing systemic therapy for patients with pancreatic cancer: expert perspectives from the Aus… DOI 10.1080/14737140.2017.1369882↗
- Daniel Gerald Croagh · 2 shared papers, 2017–2021 · strength 0.17
- Nick Pavlakis · 1 shared paper, 2022 · strength 0.13
- Amitesh Chandra Roy · 1 shared paper, 2022 · strength 0.13
- Trevor Leong · 1 shared paper, 2022 · strength 0.13
- Adnan M. Nagrial · 1 shared paper, 2022 · strength 0.13
- Christos Stelios Karapetis · 1 shared paper, 2022 · strength 0.13
- Niall Christopher Tebbutt · 1 shared paper, 2022 · strength 0.13
- Mike Nguyen · 1 shared paper, 2022 · strength 0.13
- Daniel John Renouf · 1 shared paper, 2022 · strength 0.13
- John Raymond Zalcberg · 1 shared paper, 2021 · strength 0.10
- Joanne Lundy · 1 shared paper, 2021 · strength 0.10
- Charles H. C. Pilgrim · 1 shared paper, 2021 · strength 0.10
- Marion Harris · 1 shared paper, 2021 · strength 0.10
- Rhys Vaughan · 1 shared paper, 2021 · strength 0.10
- Belinda Lee · 1 shared paper, 2021 · strength 0.10
- Manoop S. Bhutani · 1 shared paper, 2021 · strength 0.10
- Brendan John Jenkins · 1 shared paper, 2021 · strength 0.10
- Radka Lordick Obermannova · 1 shared paper, 2017 · strength 0.07
- Ben J. Lawrence · 1 shared paper, 2017 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.